The prevalence of psychiatric comorbidities in adult ADHD compared with non-ADHD populations: A systematic literature review

WS Choi, YS Woo, SM Wang, HK Lim, WM Bahk - PloS one, 2022 - journals.plos.org
Comorbid psychiatric disorders in adults with ADHD are important because these
comorbidities might complicate the diagnosis of ADHD and also worsen the prognosis …

ADHD: Current concepts and treatments in children and adolescents

R Drechsler, S Brem, D Brandeis, E Grünblatt… - …, 2020 - thieme-connect.com
Attention deficit hyperactivity disorder (ADHD) is among the most frequent disorders within
child and adolescent psychiatry, with a prevalence of over 5%. Nosological systems, such as …

Autism in England: assessing underdiagnosis in a population-based cohort study of prospectively collected primary care data

E O'Nions, I Petersen, JEJ Buckman… - The Lancet Regional …, 2023 - thelancet.com
Background Autism has long been viewed as a paediatric condition, meaning that many
autistic adults missed out on a diagnosis as children when autism was little known. We …

Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases

L Zhang, L Li, P Andell, M Garcia-Argibay… - JAMA …, 2024 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …

Overdiagnosis of attention-deficit/hyperactivity disorder in children and adolescents: a systematic sco** review

L Kazda, K Bell, R Thomas, K McGeechan… - JAMA network …, 2021 - jamanetwork.com
Importance Reported increases in attention-deficit/hyperactivity disorder (ADHD) diagnoses
are accompanied by growing debate about the underlying factors. Although overdiagnosis is …

Pharmacologic treatment of attention deficit–hyperactivity disorder

S Cortese - New England Journal of Medicine, 2020 - Mass Medical Soc
Pharmacologic Treatment of ADHD Amphetamines and methylphenidate and, less often,
nonstimulants (atomoxetine, clonidine, and guanfacine) are used to treat ADHD …

Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study

R Brauer, B Alfageh, JE Blais, EW Chan… - The Lancet …, 2021 - thelancet.com
Summary Background The WHO Comprehensive Mental Health Action Plan 2013–2030
encourages routine collection and reporting of a set of essential mental health indicators …

Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic …

KKC Man, A Häge, T Banaschewski, SK Inglis… - The Lancet …, 2023 - thelancet.com
Background Methylphenidate is the most frequently prescribed medication for the treatment
of ADHD in children and adolescents in many countries. Although many randomised …

Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis

L Zhang, H Yao, L Li, E Du Rietz, P Andell… - JAMA Network …, 2022 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades, but there are concerns regarding their cardiovascular …

Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults

S Weibel, O Menard, A Ionita, M Boumendjel… - L'encephale, 2020 - Elsevier
Attention deficit with or without hyperactivity disorder (ADHD) is one of the most frequent
neuropsychiatric disorders, and affects 2–4% of adults. In contrast with many European …